These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 21462798)

  • 1. The Pictorial Representation of Illness and Self Measure (PRISM) instrument reveals a high burden of suffering in patients with chronic urticaria.
    Töndury B; Muehleisen B; Ballmer-Weber BK; Hofbauer G; Schmid-Grendelmeier P; French L; Büchi S
    J Investig Allergol Clin Immunol; 2011; 21(2):93-100. PubMed ID: 21462798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pictorial Representation of Illness and Self Measure (PRISM): A novel visual instrument to measure quality of life in dermatological inpatients.
    Mühleisen B; Büchi S; Schmidhauser S; Jenewein J; French LE; Hofbauer GF
    Arch Dermatol; 2009 Jul; 145(7):774-80. PubMed ID: 19620558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. PRISM (pictorial representation of illness and self measure): a novel visual instrument to assess pain and suffering in orofacial pain patients.
    Streffer ML; Büchi S; Mörgeli H; Galli U; Ettlin D
    J Orofac Pain; 2009; 23(2):140-6. PubMed ID: 19492538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Validating PRISM (Pictorial Representation of Illness and Self Measure) as a measure of suffering in chronic non-cancer pain patients.
    Kassardjian CD; Gardner-Nix J; Dupak K; Barbati J; Lam-McCullock J
    J Pain; 2008 Dec; 9(12):1135-43. PubMed ID: 18755635
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Turkish version of the chronic urticaria quality of life questionnaire: cultural adaptation, assessment of reliability and validity.
    Kocatürk E; Weller K; Martus P; Aktas S; Kavala M; Sarigul S; Baiardini I; Canonica GW; Brzoza Z; Kalogeromitros D; Maurer M
    Acta Derm Venereol; 2012 Jul; 92(4):419-25. PubMed ID: 21918791
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Minimal important difference (MID) of the Dermatology Life Quality Index (DLQI): results from patients with chronic idiopathic urticaria.
    Shikiar R; Harding G; Leahy M; Lennox RD
    Health Qual Life Outcomes; 2005 May; 3():36. PubMed ID: 15907211
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Urticaria Severity Score: a sensitive questionnaire/index for monitoring response to therapy in patients with chronic urticaria.
    Jariwala SP; Moday H; de Asis ML; Fodeman J; Hudes G; de Vos G; Rosenstreich D
    Ann Allergy Asthma Immunol; 2009 Jun; 102(6):475-82. PubMed ID: 19558005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of PRISM (Pictorial Representation of Illness and Self Measure) as a novel visual assessment tool for the burden of suffering in tinnitus patients.
    Peter N; Kleinjung T; Horat L; Schmidt-Weitmann S; Meyer M; Büchi S; Weidt S
    Health Qual Life Outcomes; 2016 Mar; 14():47. PubMed ID: 27001548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the Dermatology Life Quality Index as an outcome measure for urticaria-related quality of life.
    Lennox RD; Leahy MJ
    Ann Allergy Asthma Immunol; 2004 Aug; 93(2):142-6. PubMed ID: 15328673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A self-administered version of a brief measure of suffering: first aspects of validity.
    Rumpf HJ; Löntz W; Uesseler S
    Psychother Psychosom; 2004; 73(1):53-6. PubMed ID: 14665796
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The German version of the Chronic Urticaria Quality-of-Life Questionnaire: factor analysis, validation, and initial clinical findings.
    Młynek A; Magerl M; Hanna M; Lhachimi S; Baiardini I; Canonica GW; Brzoza Z; Kasperska-Zajac A; Rogala B; Zalewska-Janowska A; Zuberbier T; Maurer M
    Allergy; 2009 Jun; 64(6):927-36. PubMed ID: 19453340
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Suffering quantified? Feasibility and psychometric characteristics of 2 revised versions of the Pictorial Representation of Illness and Self Measure (PRISM).
    Wouters EJ; Reimus JL; van Nunen AM; Blokhorst MG; Vingerhoets AJ
    Behav Med; 2008; 34(2):65-78. PubMed ID: 18682339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cross-cultural adaptation of the Brazilian-Portuguese version of the chronic urticaria quality-of-life questionnaire - CU-Q2oL.
    Dias GA; Pires GV; Valle SO; França AT; Papi JA; Dortas SD; Levy SA; Baiardini I; Canonica GW
    Allergy; 2011 Nov; 66(11):1487-93. PubMed ID: 21899558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pictorial representation of illness and self measure (PRISM): an effective tool to assess the burden of psoriasis.
    Fotiou K; Hofmann M; Kaufmann R; Thaci D
    J Eur Acad Dermatol Venereol; 2015 Dec; 29(12):2356-62. PubMed ID: 26332649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autologous serum skin test vs autologous plasma skin test in patients with chronic urticaria: evaluation of reproducibility, sensitivity and specificity and relationship with disease activity, quality of life and anti-thyroid antibodies.
    Kocatürk E; Kavala M; Kural E; Sarıgul S; Zındancı I
    Eur J Dermatol; 2011; 21(3):339-43. PubMed ID: 21697031
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Disease activity only moderately correlates with quality of life impairment in patients with chronic spontaneous urticaria.
    Koti I; Weller K; Makris M; Tiligada E; Psaltopoulou T; Papageorgiou C; Baiardini I; Panagiotakos D; Braido F; Maurer M
    Dermatology; 2013; 226(4):371-9. PubMed ID: 23942323
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The levels of depression, anxiety and quality of life in patients with chronic idiopathic urticaria.
    Engin B; Uguz F; Yilmaz E; Ozdemir M; Mevlitoglu I
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):36-40. PubMed ID: 18181971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life instrument for Turkish people with skin diseases.
    Gurel MS; Yanik M; Simsek Z; Kati M; Karaman A
    Int J Dermatol; 2005 Nov; 44(11):933-8. PubMed ID: 16336527
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pictorial Representation of Self and Illness Measure (PRISM): a graphic instrument to assess suffering in fatigued cancer survivors.
    Gielissen MF; Prins JB; Knoop H; Verhagen S; Bleijenberg G
    Psychol Assess; 2013 Jun; 25(2):658-63. PubMed ID: 23339314
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Desloratadine 5 mg once daily improves the quality of life of patients with chronic idiopathic urticaria.
    Lachapelle JM; Decroix J; Henrijean A; Roquet-Gravy PP; De Swerdt A; Boonen H; Lecuyer M; Suys E; Speelman G; Vastesaeger N
    J Eur Acad Dermatol Venereol; 2006 Mar; 20(3):288-92. PubMed ID: 16503889
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.